Trials / Unknown
UnknownNCT05697185
Safety and Efficacy of Evolocumab in Ischemic Stroke
Safety and Efficacy of Evolocumab in in Combination With Statin Therapy in Adults With Ischemic Stroke
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Second Affiliated Hospital of Guangxi Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to evaluate the effect of evolocumab in combination with statin therapy (atorvastatin) in acute ischemic stroke (AIS).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Evolocumab | Patients were randomly assigned of the ratio of 1:1 using a computer-generated random number and divided into two treatment groups: the statin alone therapy and the evolocumab plus statin therapy. |
Timeline
- Start date
- 2023-02-01
- Primary completion
- 2024-02-01
- Completion
- 2024-12-01
- First posted
- 2023-01-25
- Last updated
- 2023-01-25
Source: ClinicalTrials.gov record NCT05697185. Inclusion in this directory is not an endorsement.